TBA (last known deadline was January 15, 2010)
These awards, funded by Takeda Pharmaceuticals North America, Inc., are granted to established diabetes investigators to support a postdoctoral fellow being trained in the area of diabetes and cardiovascular disease. Awards are $45,000 a year for up to two years. No indirect costs may be requested.